{"name":"Center for Ophthalmic and Vision Research, LLC","slug":"center-for-ophthalmic-and-vision-research-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cyclosporine 0.09% Ophthalmic Solution","genericName":"Cyclosporine 0.09% Ophthalmic Solution","slug":"cyclosporine-0-09-ophthalmic-solution","indication":"Dry eye disease (keratoconjunctivitis sicca)","status":"marketed"}]}],"pipeline":[{"name":"Cyclosporine 0.09% Ophthalmic Solution","genericName":"Cyclosporine 0.09% Ophthalmic Solution","slug":"cyclosporine-0-09-ophthalmic-solution","phase":"marketed","mechanism":"Cyclosporine is a calcineurin inhibitor that suppresses T-cell activation and reduces inflammatory cytokine production in the eye.","indications":["Dry eye disease (keratoconjunctivitis sicca)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdTNpekh6NlRYVGRPc1ZQSmZydmU2Z3NEWXFaNkpBVGVXbHFsaTk4dTUta3hvbXNwdlpCOWhZT0FkVDVsb0NXaXRJSkhTcXRIcE1lNzZHYzZJZnVIdW5jeHZYR0tqbllwU1VQSno0Y3hWb1dtMXFsX0REaHZZbldxWUJsQ3prcmpvZzVCSkxpclhVYnFzNFBES1BHOHJ2TXNmLXBKNDZn0gG7AUFVX3lxTFBDYUJ1RXZBdUVxM2d1cnRaV2ZaazFNRXhnUEVNb3R2VnZWQzk4MXF6NUpGYXZvMUVUUldvRVZVS2t2VEdPYko4cjlqVnV3djZOSmNXbTIyTmd3eU5VR3l2ZHVLQmJzcFFHd0R3ejh2bGQyamZra21QNmxDR05VMWdiOHBEUFFTVzBEdHdOVVN1NUlsbTh2TEYyOHMyMVduNEZlRnZ0UExjY2tDNjR2aDhTR3ZuMGtKTXpiUEE?oc=5","date":"2026-04-07","type":"pipeline","source":"Patch","summary":"3M Bottles Of Eye Drops Recalled Over Sterility Concerns; Cause Unclear - Patch","headline":"3M Bottles Of Eye Drops Recalled Over Sterility Concerns; Cause Unclear","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOM2ttUWVDWC01Z21WOFgtUDFLVVZESnhYYUVMWHJvVmNTak4zUVRGSHp6QzI5eFhnVHJYWTNFcjBpZDlDZ09PaUM4Qk1paTB4YnhhWUN2bkQ2R3VkcXNpTE5NdTFTWUh2WWlLWVBLMkQyakdIT2dTMk80NmVCUXpRRzVuR2IwRXF3SVI2dm9FZkZNSjJVeXpwZHFHVVoxelg3dDNZZ0wxTW13TzVQTHg2OFJ1YkhMVTJnSWhWVDcyeGVzWnFCU3FqU05nUEF0My05ZUFqTjZuSEcxQQ?oc=5","date":"2025-12-19","type":"regulatory","source":"MedShadow Foundation","summary":"FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations - MedShadow Foundation","headline":"FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQWG1IZkxwTXloRWdEVEQ1N0dXUlZZTzR0QldRVjU5Z0FNR05YNkNac1J6NHMtbHZtR04wUEItSUhUaVVlMXVzdkI5SThTVHlvTzZ5dThhRDhGRHBzNGdnSlY5UzczczRzVlVSZk5wM1dCTFhkX05hX0JtT0l3X1pDRzVwV2ZuRWpSU2k2cVBTb2d4MzEtR3hPQ2M5Y1VZd3B6SnBXV2RzYlVuUUtsQS1nTA?oc=5","date":"2025-10-29","type":"pipeline","source":"University of Miami","summary":"University of Miami Health System’s Bascom Palmer Eye Institute Opening in Abu Dhabi - University of Miami","headline":"University of Miami Health System’s Bascom Palmer Eye Institute Opening in Abu Dhabi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxObUZzWFIxZVhiQjMyUU5kVUpsUnJjb1FBZGlwLXE2VDc5OWw5ZTBJVVhzeFRwYXZlUXYxdENvd2VEQlY2UndWWjJQMHVBWHBLRDAwYmxGa2RFc2labm94eFlfLXVMdWhTamtwaGFYNkZ1X2M1YkROMW85UlpIMjBWQmZIekxWLU5zcUc4Z3FpVVppS09RVWNzVDJEdWEtM0ltZ3BJYTgyM21ZdXBGa0cyZVFOOS05ci1jeFE?oc=5","date":"2025-10-21","type":"pipeline","source":"Fierce Biotech","summary":"Science Corp.'s retinal implant restores some vision in patients with macular degeneration - Fierce Biotech","headline":"Science Corp.'s retinal implant restores some vision in patients with macular degeneration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQQURLMzRsb3daLXRtakF2cW9rM01SV1psc2hhcG1nVndBZjhGUG1DM0sxdXphQm5qYlhhNlZjS21hc2hCRlpfVHNUaEJZeWpGYXRZUTZLUzZMOWo2OXd5VU1yUmVQZUtKVWVWUzd4YWdKTFdDbzVNSHdwNXhCXzNjV1JReW1TV0s4N0o5YnNuNTNwamtDX0JrYg?oc=5","date":"2025-07-17","type":"pipeline","source":"Healio","summary":"Cequa reduces dry eye signs, symptoms in 7 days - Healio","headline":"Cequa reduces dry eye signs, symptoms in 7 days","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPX3NjOEFlR3VxeTBBN19vazlSZHFiVGNWcFZpaDJfMndUYmxseG5KLUtkNVBFUU5XRF9idkNhNnNreUNlZlFlajFEOGlVZkhxYS1MLUdqLTNWQXRtdmRudndyY283TF9SOVlfMFdxYXlmLWNKZUtrTmdfQmpIYlJ6MUowY0NNb3NCTUUyU3d5QVczQU9EQmlhdXFXem9fbWJvdlFoYg?oc=5","date":"2025-05-12","type":"pipeline","source":"Medscape","summary":"ARVO Attendees Hear Call to Save National Eye Institute - Medscape","headline":"ARVO Attendees Hear Call to Save National Eye Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1yRmROaXZfbmIyRi1BclpCSUlrU3d4UmxGNTlZTkNLQzBYUkRsV1poSTRIY0ZoNDA4WXN2WGQ3UDJzb1JfRmpoSW5mQ2owYXZ6WGM5dFFHdGtMV2FuVk5ES3Q0cUVtNzZGWXBKQmtIa1dFT1RVcUh3bVRn?oc=5","date":"2025-05-01","type":"pipeline","source":"Lawsuit Information Center","summary":"Elmiron Eye Class Action Lawsuit Settlement - Lawsuit Information Center","headline":"Elmiron Eye Class Action Lawsuit Settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaURVUTZ2aFNCLWRvc0d4a3ZPV09JYTlNUUxET3YtOVJwN1ljemg4bzdxSUR1QVZScnBqUkN1Zml2RkxMc3dyTjh6NjVPaEFtVmVHNDlqdGVVU1FKZkFVUzlBT2dkQU9JbGc2WHVHQjlYcWRoWTZfQXZqb0hUTkxPdGdaRUhtNTVkcDdhaWZWUVNrUFNFXzJPVUFMOUZfX0VUcS1HenQ0OEZfTld3V1pFSWVqejFEaUJGcm0wejYyc0N5a1BUb0ZmemxrN2wyZnBQbTZmU3pzckpmVVRTNHdLa2xpb1Y?oc=5","date":"2024-03-04","type":"pipeline","source":"Business Wire","summary":"NVISION Eye Centers' Subsidiary, NVISION Clinical Research, Rapidly Expands Under New Leadership - Business Wire","headline":"NVISION Eye Centers' Subsidiary, NVISION Clinical Research, Rapidly Expands Under New Leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBYS3N1UTdUZmplTVlabVNHXzdqUlFiX2ZxOVFKb0hlZldiWkZBRzFiOC03T2lpOXJxVFZNMF9oUlRTU2g1cURlM3FYMnVsZU1XRjlLemFTVHlDcnhmZENB?oc=5","date":"2024-02-05","type":"pipeline","source":"Nature","summary":"The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach | Eye - Nature","headline":"The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach | Eye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxNU3dhbDBTTHpGMktyNmQxZGtUdUFXYm5nT3I3VFlQTF9TUEh3SHdPX1lhTlR3blVRdDZxYzZ1RXZlOHVNVWt3MnJxRzlMQmVjM2FwT3RzMU43akxXc1czQmE5UGtQQ09VbUM4cjN4T3RhdnNTYlNjTVJ0UE9oSGVNSHQ1UWJteTZfTnBuSF9QdXE0ZWNKNXN1Mm90MWhHSUFsaWc3dEItNkZKeWw4b1Fla0xiV0RaR0VvMEJoek5HSU5EdGhqRVBaQnlUOHR5ZVE2XzF5ZkpjSjZMeVY3dkd4a0lOR3MxV3JwbW4yekdFUFNJN2drNkZocC1pNlpETVhLdzFRcVZiejRtQmNlOHNmNGZFTUVZcndyQzJBYQ?oc=5","date":"2023-04-21","type":"pipeline","source":"PR Newswire","summary":"Janssen to Highlight Innovation in Retinal Pipeline at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting - PR Newswire","headline":"Janssen to Highlight Innovation in Retinal Pipeline at the Association for Research in Vision and Ophthalmology (ARVO) 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOMmk0RHBtaENzckNYSW9YQTA4QXJhbXNlcE5JdlBrX1dXenJzeFBueGU1ZzQ2ZXpIMFc3MmtRQ3BfX1lnSTlLb1lnM1JSWllKM3Eyb0lzNE5ua255SWluanFsNGo3RFljb2gxTWtnb1p2ZWlhMVZLUmV6TFozWTZQVDNLRm5ReWN1QzhEa0J1NG02dnZlR19xVmFZcjNXQjg4ZlFWdEx1RlFua1RiOGk0Mg?oc=5","date":"2023-03-14","type":"regulatory","source":"University of California - Davis Health","summary":"FDA warns people not to use 2 types of eye drops due to contamination - University of California - Davis Health","headline":"FDA warns people not to use 2 types of eye drops due to contamination - University of California","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-09-01","type":"pipeline","source":"University of Colorado Anschutz","summary":"CellSight Teams Clinch Top Two of Three Awards in National Eye Institute Competition - University of Colorado Anschutz","headline":"CellSight Teams Clinch Top Two of Three Awards in National Eye Institute Competition","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}